ヒト生殖技術：製品と世界市場

世界のヒト生殖技術の市場規模は、2021年の161億米ドルから、予測期間中は7%のCAGRで推移し、2022年に171億米ドルから、2027年には240億米ドルの規模に成長すると予測されています。

避妊の部門が2021年の93億米ドルから、7.8%のCAGRで推移し、2022年に100億米ドル、2027年には147億米ドルの規模に、不妊治療の部門が2021年の25億米ドルから、7.5%で推移し、2022年に27億米ドル、2027年には39億米ドルの規模に成長すると予測されています。

当レポートでは、世界のヒト生殖技術の市場を調査し、産業概要、COVID-19の影響、市場規模の推移・予測、各種区分・地域別の内訳、特許情勢、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 産業概要

• 生殖器系の構造・機能
• リプロダクティブヘルスの課題・動向
• 避妊保険
• 市販の経口避妊薬
• 着床前遺伝子診断
• デザイナーベビー
• 避妊薬の新しい用途
• 老化と不妊症
• 避妊パッチによる死亡
• 性機能障害と癌
• 不妊症と癌
• 不妊治療のシグナル伝達経路
• マーケティング戦術
• 男性の避妊
• 女性をターゲットにしたマーチャンダイジング
• 偽造品
• 余剰胚・胎児
• 幹細胞およびその他の課題：主な見解
• 議論の対象となる胚の処分
• 人口統計

第4章 不妊市場

• 不妊症のイントロダクション・概要
• 不妊症の定義
• 不妊症の病因
• 生殖能力の評価
• 原因不明の不妊症
• 多胎出産
• アジアの因子

第5章 COVID-19の影響

• イントロダクション
• COVID-19：医療機器および製薬産業への影響
• 選択的手術の辞退/遅延
• COVID-19のサプライチェーンへの影響
• 米国のサプライチェーン：COVID-19の影響
• 欧州のサプライチェーン：COVID-19の影響
• アジア太平洋のサプライチェーン：COVID-19の影響
• 中国：COVID-19の影響
• 医療機器および医薬品に対するCOVID-19の影響
• 重要デバイスに対するCOVID-19の影響
• COVID-19の影響

第6章 治療法

• 不妊治療薬
• イントロダクション・タイプ
• 市場収益・予測
• 不妊製品の今後の進歩
• 競合分析

第7章 生殖補助技術

• イントロダクション
• タイプ
• 体外受精
• 排卵誘発
• 採卵
• 細胞質内精子注入法（ICSI）
• 受精
• 胚移植
• 体外受精の結果
• GIFT
• ZIFT
• レンタル子宮
• 卵子提供
• 凍結胚
• 米国の不妊治療クリニック
• 市場収益・予測
• 生殖補助医療の今後の動向
• 競合分析

第8章 不妊診断

• タイプ
• 尿検査
• 市場収益・予測
• 競合分析
• 不妊治療診断の将来の進歩
• 不妊症市場の総収益・予測

第9章 避妊市場

• イントロダクション・概要
• 医薬品
• タイプ
• その他の避妊薬レジメン
• 市場収益・予測
• 競合分析
• 処方デバイス
• 市場収益・予測
• 競合分析
• 避妊の将来の進歩
• 総市場収益・予測

第10章 性機能障害市場

• イントロダクション・概要
• 性機能障害のタイプ
• 性機能障害の原因
• 性機能障害の人口統計
• 医薬品
• イントロダクション・タイプ
• 市場収益・予測
• 競合分析
• デバイス
• 市場収益・予測
• 性機能障害の将来の進歩
• 総市場収益・予測

第11章 特許

• 特許分析：製造業者別
• 特許：企業別
• 特許：出願別
• 不妊治療
• 避妊
• 性機能障害
• 主要製造業者

第12章 総市場

• 世界の生殖技術および製品市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域
• 市場規模：カテゴリー別
• 参入事業者：カテゴリー別
• 市場規模：製品タイプ別

第13章 競合情勢

第14章 企業プロファイル

• ACTAVIS, INC.
• BAYER AG
• BRISTOL-MYERS SQUIBB CO.
• CHURCH & DWIGHT COMPANY INC.
• COOPERSURGICAL INC.
• ELI LILLY & CO.
• EMD SERONO, INC.
• FERRING PHARMACEUTICALS
• GLAXOSMITHKLINE PLC
• JANSSEN PHARMACEUTICAL
• MERCK INC.
• NOVARTIS INTERNATIONAL AG
• PFIZER INC.
• PRINCETON BIOMEDITECH CORP.
• QUIDEL CORP.
• TEVA PHARMACEUTICALS.
• VIVUS INC.
• 米国の不妊治療クリニックのリスト
• 企業リスト

第15章 付録：頭字語

List of Tables

• Summary Table : Global Market for Human Reproductive Technologies and Products, by Product Type, Through 2027
• Table 1 : Structural Homologues of the Male and Female Reproductive Systems
• Table 2 : U.S. Live Birth Rates, 2000-2020
• Table 3 : U.S. Population, by Selected Age Groups, and by Percent of Total Population, 2010-2030
• Table 4 : Characteristics of Women Who Have Had a Child in the Last Year, 2008 and 2010
• Table 5 : Women Who Have Had a Child in the Last Year, by Age and Labor FORCE Status, 1980-2008
• Table 6 : Contraceptive Use Share, by Type, by Age, Ethnic Group and Marital Status
• Table 7 : Birth Rate in Europe, by Country and Year, 1960-2020
• Table 8 : Selected Prescription Fertility Drugs
• Table 9 : Global Infertility Pharmaceuticals Market, Through 2027
• Table 10 : Infertility Drugs in Development
• Table 11 : Global Infertility Pharmaceutical Manufacturer Market, 2021
• Table 12 : National Summary of Assistive Reproductive Therapies in U.S., 2020
• Table 13 : National Assistive Reproductive Therapies Cycle Profile, 2019
• Table 14 : Pregnancy Success Rates, 2019
• Table 15 : Number of IVF Clinics/Centers by Selected Countries
• Table 16 : Global Assistive Reproductive Technologies Market, Through 2027
• Table 17 : Global Infertility Assistive Reproductive Products Manufacturer Market, 2021
• Table 18 : Global Fertility Diagnostics Market, by Product Type, Through 2027
• Table 19 : Global Fertility Diagnostic Manufacturer Market, 2021
• Table 20 : Global Infertility Treatments Market, by Product Type, Through 2027
• Table 21 : Contraceptive Status and Use Rates, U.S. Women Aged 15-49, 2015-2017
• Table 22 : Contraceptive Use, by Region, 2015 and 2030
• Table 23 : Most Commonly Used Oral and Transdermal Contraceptives
• Table 24 : Estrogen and Progestin Hormone Doses in Combined Birth Control Pills
• Table 25 : Potency of Different Oral Contraceptive Progestins
• Table 26 : Current Pill Problems and Choice of Pill to Switch To
• Table 27 : Global Contraceptive Pharmaceuticals Market, by Product Type, Through 2027
• Table 28 : Global Contraceptive Pharmaceutical Manufacturer Market, 2021
• Table 29 : Selected Contraceptive Device Treatments, 2021
• Table 30 : Global Contraceptive Devices Market, by Product Type, Through 2027
• Table 31 : Global Contraceptive Device Manufacturer Market, 2021
• Table 32 : Contraceptives in Development
• Table 33 : Global Contraceptive Products Market, by Product Type, Through 2027
• Table 34 : Selected Sexual Dysfunction Pharmaceutical Treatments
• Table 35 : Global Sexual Dysfunction Pharmaceuticals Market, by Product Type, Through 2027
• Table 36 : Global Sexual Dysfunction Pharmaceuticals Manufacturer Market, 2021
• Table 37 : Selected Sexual Dysfunction Device Treatments
• Table 38 : Global Sexual Dysfunction Devices Market, by Product Type, Through 2027
• Table 39 : Global Sexual Dysfunction Devices Manufacturer Market, 2021
• Table 40 : Sexual Dysfunction Drugs in Development
• Table 41 : Global Sexual Dysfunction Treatments Market, by Product Type, Through 2027
• Table 42 : Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 2015-Present
• Table 43 : Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 1976-Present
• Table 44 : Patent Analysis, by Selected Leading Reproductive Treatment Manufacturer, 1976-Present
• Table 45 : Global Reproductive Technologies and Products Market, Through 2027
• Table 46 : Global Reproductive Technologies and Products Market, by Region, Through 2027
• Table 47 : North American Reproductive Technologies and Products Market, by Country, Through 2027
• Table 48 : European Reproductive Technologies and Products Market, by Country, Through 2027
• Table 49 : Asia-Pacific Reproductive Technologies and Products Market, by Country, Through 2027
• Table 50 : RoW Reproductive Technologies and Products Market, Through 2027
• Table 51 : Global Reproductive Technologies and Products Market, by Region, 2021
• Table 52 : Global Reproductive Technologies and Products Market, by Region, 2027
• Table 53 : Global Reproductive Technologies and Products Market, by Product Type, Through 2027
• Table 54 : Global Reproductive Technologies and Products Market, 2019
• Table 55 : Reproductive Industry Participants, by Product Category
• Table 56 : Global Reproductive Technologies and Products Market, by Product Type, Through 2017
• Table 57 : List of Companies
• Table 58 : Acronyms Used in This Report

List of Figures

• Summary Figure A : Global Market for Human Reproductive Technologies and Products, by Product Type, 2019-2027
• Summary Figure B : Global Market Share of Human Reproductive Technologies and Products, by Product Type, 2021
• Figure 1 : U.S. Live Birth Rates, 2000-2020
• Figure 2 : U.S. Population Selected Age Groups, by Percent of Total Population, 2010-2030
• Figure 3 : Global Infertility Pharmaceutical Manufacturer Market Share, 2021
• Figure 4 : Global Infertility Assistive Reproductive Products Manufacturer Market Share, 2021
• Figure 5 : Global Fertility Diagnostic Manufacturer Market Share, 2021
• Figure 6 : Global Infertility Treatments Market, by Product Type, 2019-2027
• Figure 7 : Global Contraceptive Pharmaceuticals Manufacturer Market Share, 2021
• Figure 8 : Global Contraceptive Device Manufacturer Market Share, 2021
• Figure 9 : Global Contraceptive Products Market, by Product Type, 2019-2027
• Figure 10 : Global Sexual Dysfunction Pharmaceuticals Manufacturer Market Share, 2021
• Figure 11 : Global Sexual Dysfunction Devices Manufacturer Market Share, 2021
• Figure 12 : Global Sexual Dysfunction Treatments Market, by Product Type , 2019-2027
• Figure 13 : Global Reproductive Technologies and Products Market Share, by Region, 2021
• Figure 14 : Global Reproductive Technologies and Products Market Share, by Region, 2027
• Figure 15 : Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
• Figure 16 : Number of Selected Manufacturers, by Segment, 2019
• Figure 17 : Global Reproductive Technologies and Products Market Share, 2019
• Figure 18 : Global Reproductive Technologies and Products Market, by Product Type, 2019-2027

Highlights:

The global market for human reproductive technologies and products is valued at $16.1 billion in 2021 and is estimated to grow from $17.1 billion in 2022 to $24 billion in 2027 with a compound annual growth rate (CAGR) of 7% for the period of 2022-2027.

The contraceptive products as a segment of the global human reproductive technologies market is valued at $9.3 billion in 2021 and is estimated to grow from $10 billion in 2022 to $14.7 billion in 2027 with a CAGR of 7.8% for the period of 2022-2027.

The infertility pharmaceuticals products as a segment of the global human reproductive technologies market is valued at $2.5 billion in 2021 and is estimated to grow from $2.7 billion in 2022 to $3.9 billion in 2027 with a CAGR of 7.5% for the period of 2022-2027

Report Scope:

The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.

The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.

Infertility market - male and female factors, pharmaceuticals, and future advancements.

• IVF.
• Assistive reproductive technologies.
• Fertility diagnostics.

Contraception - pharmaceuticals and devices.

Sexual dysfunction - pharmaceuticals and devices.

Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.

Report Includes:

• 36 data tables and 22 additional tables
• An updated review of the global markets for human reproductive products and technologies
• Analyses of the global market trends, with data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Evaluation and forecast the overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region
• In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of this reproductive health market
• Discussion of the emerging technology trends, opportunities and gaps in the market estimating current and future demand for reproductive drugs and technologies, and COVID-19 implications within the marketplace
• Identification of promising new products and technologies still in the development and pipeline stage, and assess the probability that they will be commercialized successfully in the next five years
• Review of the company competitive landscape for global human reproductive drugs market, their product portfolios, global rankings, and company value share analysis based on segmental revenues
• Key merger and acquisition deals, new product launches, and other strategic alliances within the industry
• A relevant patent analysis
• Descriptive company profiles of the leading global players, including Actavis,Inc., Bayer AG, EMD Serono,Inc. and Quidel Corp.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Update?
• Scope of Report
• Methodology
• Information Source
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

• Introduction

Chapter 3 Industry Overview

• Structure and Function of the Reproductive System
• Male
• Female
• Neuroendocrine Regulation
• Menarche
• Menstruation Cycle
• Phases of Sexual Responses
• Male Sexual Response
• Female Sexual Response
• Neurohormonal Control of the Female and Male Reproductive System
• Effects of Aging
• Issues and Trends of Reproductive Health
• Contraceptive Insurance
• Over-the-Counter Birth Control Pills
• Pre-Implantation Genetic Diagnosis
• Designer Babies
• New Use for Contraceptives
• Aging and Infertility
• Death by Contraceptive Patch
• Sexual Dysfunction and Cancer
• Infertility and Cancer
• Signaling Pathway for Fertility Treatment
• Marketing Tactics
• Male Birth Control
• Merchandising Targeting Women
• Counterfeit Products
• Surplus Embryos and Fetuses
• Stem Cell and Other Controversial Issues - Selected International Views
• Controversial Disposal of Embryos
• Demographics

Chapter 4 Infertility Market

• Introduction and Overview of Infertility
• Definition of Infertility
• Etiology of Infertility
• Evaluation of Fertility
• Unexplained Infertility
• Multiple Births
• Asia Factor

Chapter 5 COVID-19 Impact

• Introduction
• COVID-19: Impact on the Medical Devices and Pharma Industries
• Decline/Delay in Elective Procedures
• COVID-19 Impact on Supply Chain
• U.S. Supply Chain: COVID-19 Impact
• European Supply Chain: COVID-19 Impact
• APAC Supply Chain: COVID-19 Impact
• China: COVID-19 Impact
• COVID-19 Impact on Medical Device and Pharmaceutical Product Segments
• COVID-19 Impact on Critical Devices
• COVID-19 Impact on Human Reproductive Technologies and Products Markets

Chapter 6 Methods of Treatment

• Fertility Pharmaceuticals
• Introduction and Types
• Market Revenues and Forecast
• Future Advancements in Infertility Products
• Competitive Analysis

Chapter 7 Assistive Reproductive Technologies

• Introduction
• Types
• IVF
• Ovulation Induction
• Oocyte Retrieval
• Intracytoplasmic Sperm Injection (ICSI)
• Fertilization
• Embryo Transfer
• Results of IVF
• GIFT
• ZIFT
• Wombs for Rent
• Oocyte Donation
• Frozen Embryos
• United States Fertility Clinics
• Market Revenues and Forecast
• Future Trends in Assistive Reproductive Technology
• Competitive Analysis

Chapter 8 Fertility Diagnostics

• Introduction
• Types
• Urine Studies
• Market Revenues and Forecast
• Competitive Analysis
• Future Advancements in Diagnostic Fertility Treatment
• Total Infertility Market Revenues and Forecast

Chapter 9 Contraception Market

• Introduction and Overview of Contraception
• Pharmaceuticals
• Types
• Other Drug Regimens for Contraception
• Market Revenues and Forecast
• Competitive Analysis
• Prescription Devices
• Market Revenues and Forecast
• Competitive Analysis
• Future Advancements in Contraception
• Total Market Revenues and Forecast

Chapter 10 Sexual Dysfunction Market

• Introduction and Overview
• Types of Sexual Dysfunction
• Causes of Sexual Dysfunction
• Demographics of Sexual Dysfunction
• Pharmaceuticals
• Introduction and Types
• Market Revenues and Forecast
• Competitive Analysis
• Devices
• Market Revenues and Forecast
• Future Advancements in Sexual Dysfunction
• Total Market Revenues and Forecast

Chapter 11 Patents

• Patent Analysis by Manufacturer
• Patent by Company
• Patents by Application
• Infertility Treatments
• Contraception
• Sexual Dysfunction
• Leading Market Manufacturers

Chapter 12 Total Market

• Total Global Market for Reproductive Technologies and Products, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Total Market Size by Category
• Industry Participants by Category
• Total Market Size by Product Type

Chapter 13 Competitive Landscape

• Competitive Analysis

Chapter 14 Company Profiles

• ACTAVIS, INC.
• BAYER AG
• BRISTOL-MYERS SQUIBB CO.
• CHURCH & DWIGHT COMPANY INC.
• COOPERSURGICAL INC.
• ELI LILLY & CO.
• EMD SERONO, INC.
• FERRING PHARMACEUTICALS
• GLAXOSMITHKLINE PLC
• JANSSEN PHARMACEUTICAL
• MERCK INC.
• NOVARTIS INTERNATIONAL AG
• PFIZER INC.
• PRINCETON BIOMEDITECH CORP.
• QUIDEL CORP.
• TEVA PHARMACEUTICALS.
• VIVUS INC.
• Selected List of U.S. Fertility Clinics
• List of Companies

Chapter 15 Appendix: Acronyms